Latest Combined oral contraceptive pill Stories
CRESSKILL, N.J., May 2, 2012 /PRNewswire/ -- Deadlines for lawsuits over side effects of the birth control drugs Yaz and Yasmin have been moved back another 90 days, the third time deadlines have been delayed this year. The extension by Chief Judge David R. Herndon, of the U.S. District Court for the Southern District of Illinois, allows settlement negotiations to continue between Bayer and lawyers for the more than 11,500 lawsuits that have been lodged against the drugs'...
The US Drug Watchdog is now warning that with a very poorly publicized possible settlement for women, who used the birth control pills called Yaz, Yasmin, or the generic version called Ocella, and then suffered a heart attack, a stroke, or a pulmonary embolism, time might be running out to get a settlement. As a background according to the September 17th 2009 edition of the New York Times, "The FDA released a warning letter sent in September to Bayer Pharmaceuticals over Yaz &...
The US Food and Drug Administration (FDA) has begun to add information to labels of popular birth control medications to warn about the increased risk of blood clots. Bayer AG’s “Yaz” or Yasmin is one of the medications receiving the new label, though all common types of birth control pills increase a woman’s risk of potentially fatal blood clots. The FDA is following up new studies with these labels, saying certain forms of birth control like Yaz show an even higher increase...
Although women continue to lag behind men in pay, the gender wage gap has narrowed considerably since the 1960s. Now a new University of Michigan study is the first to quantify the impact of the pill on women’s labor market advances. The study shows that roughly one-third of women’s wage gains through the 1990s are due to the availability of oral contraceptives. Published online this week by the National Bureau of Economic Research as a working paper, the study was conducted by U-M...
CB-1 Weight Gainer, the most effective weight gain pill on the market, has a new formula that will go out to customers today. This new formula improves the pill’s already highly effective results in helping people gain weight fast. Orem, Utah (PRWEB) March 28, 2012 Supragenix will start sending out its new and improved formula of CB-1 Weight Gainer today. This new formula will allow CB-1 users to gain weight faster and easier than ever before by strengthening the weight gain pill's...
According to court documents filed on February 28th, 2012, New Jersey state court Judge Brian Martinotti, who is presiding over the NJ Mass Tort for NuvaRing cases (BER-L-3081-09) stated that it is anticipated by the Court that all nine of the selected "bellwether" cases will be ready to be tried on February 4th, 2013. Over in the federal court system, Judge Rodney Sippel has not yet established a firm date for the first trial in the NuvaRing MDL litigation (MDL 1964). NuvaRing...
In March 2012, Bayer Healthcare reported that it had reached agreements, without admission of liability, to settle the claims of approximately 70 plaintiffs on Yasmin/Yaz lawsuits in the U.S. at terms and conditions which Bayer views to be reasonable. Yasmin, which was approved by the FDA in 2001, and Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. They are also used to treat premenstrual...
WAYNE, N.J., March 14, 2012 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia® (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception. With this approval, Natazia is the first and...
FRONT ROYAL, Va., March 5, 2012 /PRNewswire-USNewswire/ -- In violation of the First Amendment, President Obama has ordered all Catholic nonprofits to provide their employees with so-called "modern methods of birth control.""We at Population Research Institute reject this unlawful 'mandate'," says PRI President Steven Mosher. "Not only does it violate our deeply held religious beliefs, it also violates our mission: to protect and defend innocent unborn life.""Sandra Fluke...
According to court documents, on February 15th, 2012, North Dakota resident Donna L. Praus filed a lawsuit (case no. 3:2012cv20009) in the Illinois Southern District Court against Bayer Pharmaceuticals, the company manufacturing Yasmin, claiming that she suffered an alleged deep vein thrombosis (DVT) from taking Yasmin and its similar sister Yaz. Yasmin is a birth control pill that has been on the market since 2001. Last month, as reported by the Washington monthly and BMJ, an advisory...
